Cancer Diagnostics

 

12 Organization(s)

Bellwether Bio

Business Area(s): 
Description: 

Bellwether Bio is a Seattle-based startup developing a novel bioinformatics approach to analyze circulating cell-free DNA.  First unveiled in a January 2016 Cell paper, technology was

...

Blaze Bioscience

Business Area(s): 
Description: 

Real-time cancer cell visualization for surgical applications. Blaze is working to develop Tumor Paint products and Optide*-based guided therapeutics.

Cancer Targeted Technology

Business Area(s): 
Description: 

Cancer Targeted Technology develops innovative agents for cancer that accurately detect early and advanced disease, monitor treatment efficacy

Cell Search

Business Area(s): 
Description: 

Was Veridex.

Circulating tumor cell detection

CellSight Technologies

Business Area(s): 
Description: 

CellSight's makes imaging tools to assess the response to immunotherapy..

ConquerX

Business Area(s): 
Description: 

Cynvenio Biosystems

Business Area(s): 
Description: 

Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.

Epigenomics

Business Area(s): 
Description: 

Molecular Diagnostics. Develops and commercializes innovative molecular diagnostic tests that address unmet needs in cancer screening, diagnosis and patient management.

Foundation Medicine

Business Area(s): 
Description: 

Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.

Genome Explorations (Compass Lab Services)

Business Area(s): 
Description: 

Genome Explorations, a subsidiary of Compass Laboratory Services, LLC., is a premier research institution providing global genomic profiling and molecular diagnostics. We serve academic centers, ...

GRAIL

Business Area(s): 
Description: 

Presage Biosciences

Business Area(s): 
Description: 

An oncology company that is pioneering a novel approach to evaluating patient response to drugs in clinical trials.